TrialBMC complementary and alternative medicine2019

A randomized, double blind, placebo controlled, multicenter clinical trial to assess the efficacy and safety of Emblica officinalis extract in patients with dyslipidemia.

Haridas Upadya et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.